Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F2Q3G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,754
Award facts
- Contract value 100% obligated
- $2,754.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,754.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pens on January 12, 2026, with an ultimate completion date of January 13, 2026. The contract was performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and was awarded on a competitive, non-set-aside basis. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement. The company's federal contract portfolio demonstrates extensive capability in delivering a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Zepbound, a diabetes medication, represents part of the company's consistent supply of prescription medications to support military treatment facilities and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F2Q3G?
SPE2DR26F2Q3G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F2Q3G worth?
The government has obligated $2,754 on SPE2DR26F2Q3G.
Is contract SPE2DR26F2Q3G an order under another contract?
Yes. SPE2DR26F2Q3G is a delivery order under SPE2DR25D3102, an indefinite delivery contract.
Was contract SPE2DR26F2Q3G competed?
The extent of competition for SPE2DR26F2Q3G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award